News
Plexus Ventures Launches Custom Business Development Services to Augment Clients’ Internal Expertise
In 2010, Plexus Ventures has achieved a significant milestone, 20 years in business. For the last two decades, Plexus Ventures has provided superior business development services and strategic advice to firms of all sizes in the Pharmaceutical, Biotech and Consumer...
The Business of Biotechnology (featuring Richard Brown, head of Plexus Ventures Tokyo Office)
As originally published in BioProcess International. Article by: Lorna D. McLeod All companies - large and small, biotech included - have felt the pinch of the current (or recent, depending on your point of view) recession. From huge multinational companies to virtual...
Olessia Kamp Joins Plexus Ventures as Senior Advisor in Germany
Philadelphia, Pennsylvania – Plexus Ventures announces the appointment of Olessia Kamp, based near Frankfurt, as Senior Advisor in Germany. Prior to joining Plexus, Olessia served for nearly 15 years at Berlin-Chemie AG, a subsidiary of Menarini, focusing from German...
Dr. Daniel Sieiro Mosti Joins Plexus Ventures as Scientific Associate for Gene and Cell Therapies
Philadelphia, Pennsylvania – Plexus Ventures announces the appointment of Dr. Daniel Sieiro Mosti as Scientific Associate. Dr. Sieiro is a former research fellow at Harvard Medical School where he focused on the genetic basis of tissue development in health and...
Articles
Nucleic acid delivery: Are you developing what Big Pharma seeks?
Apr 11, 2023
How can we help you?
Plexus Ventures assists with M&A, divestments, licensing, strategic advice and consulting.
Subscribe to
Plexus News
Follow Us
Check out Plexus Ventures and other industry news shared daily.